about
Chemotherapeutic Dose Scheduling Based on Tumor Growth Rates Provides a Case for Low-Dose Metronomic High-Entropy Therapies.The prisoner's dilemma as a cancer model.AN EVOLUTIONARY MODEL OF TUMOR CELL KINETICS AND THE EMERGENCE OF MOLECULAR HETEROGENEITY DRIVING GOMPERTZIAN GROWTH.Capitalizing on competition: An evolutionary model of competitive release in metastatic castration resistant prostate cancer treatmentHybrid Automata Library: A flexible platform for hybrid modeling with real-time visualizationCellular interactions constrain tumor growthThe Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game TheoryTowards Multidrug Adaptive TherapyMultidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy
P50
Q46260077-E0CC1214-2E11-4BCD-805B-3BA41577A449Q46495434-1EA8EF3B-906A-40C0-9D27-CBB7CAA59E4DQ55317027-50C84BBA-12E8-49D2-8A12-52D9E65ED01CQ57467565-5B5B3CE4-B35D-4975-BC07-E8C72BD62726Q90186515-8DAC91E6-74AD-4ABC-A4C3-420E93D9ACD3Q91186022-294B14A1-24A0-4FA2-B2A3-548AB16B5AF3Q91453145-0EE1035B-B578-47FC-AEC0-EC58C01BA189Q92710212-C05E8D03-71D2-4B86-AE9E-72A8D1A5D1CCQ93137200-6F46EC51-B73A-4DC5-8C03-A3341EE83247
P50
description
researcher
@en
wetenschapper
@nl
name
Jeffrey West
@en
Jeffrey West
@nl
type
label
Jeffrey West
@en
Jeffrey West
@nl
prefLabel
Jeffrey West
@en
Jeffrey West
@nl
P31
P496
0000-0001-9579-4664